Study of a new drug with chemo for cancer of unknown primary
Part of Cancer clinical trials.
This trial tests a new drug (F520) combined with two chemotherapy drugs for people whose cancer started in an unknown place in the body. It aims to see if the combination shrinks tumors and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your cancer is confirmed by biopsy but doctors don't know where it started.
- You have not had chemotherapy or other treatments for this cancer yet.
- You have at least one tumor that can be measured on scans.
- You are well enough to do daily activities (ECOG score 0 or 1).
- Your organs (kidneys, liver, blood counts) work well enough as per blood tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with cancer that has spread to other parts of the body but where doctors cannot find the original tumor (called cancer of unknown primary). The trial aims to improve prediction of how the cancer will behave and to personalize treatment. Participants will have a biopsy of the metastatic area, and researchers will use this to better understand the cancer and guide treatment options.
This trial is for people with cancer of unknown primary (CUP), meaning cancer that started in an unknown place in the body. It aims to use advanced genomic testing (looking at your tumor's DNA) on your stored tumor sample and blood to find clues about where the cancer began and possible treatment options.
This trial tests a radioactive medicine (Lu-177 FAP-2286) that seeks out and delivers radiation directly to cancer cells. It is for people whose cancer started in an unknown place and has not responded to their first chemotherapy.
This trial is for people whose cancer started in an unknown place (cancer of unknown primary). It uses a special test called PaCIFiC-CUP to help classify the cancer, which may guide better treatment choices.
This study tests new drug combinations for people with various advanced cancers that have progressed after standard treatment, or in some cases, as a first treatment. It aims to see if these combinations are safe and effective. The study is divided into groups based on cancer type and treatment history, so not everyone will qualify for every group.
This study tests how well and how safely different combinations of cancer drugs work for people with metastatic or inoperable locally advanced breast cancer. It may help by finding a better treatment option and collecting information to guide future care.
Hear when a new Cancer of Unknown Primary Site trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.